Aspira Women's Health Inc.

1.07+0.1279+13.58%Vol 368.67K1Y Perf -79.02%
Aug 9th, 2022 16:00 DELAYED
BID0.8100 ASK1.07
Open0.9828 Previous Close0.9421
Pre-Market- After-Market1.07
 - -  - -%
Target Price
3.00 
Analyst Rating
Strong Buy 1.00
Potential %
180.37 
Finscreener Ranking
★★★★     54.96
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★     45.18
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★+     54.44
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
★★★★ —    -
Price Range Ratio 52W %
17.61 
Earnings Rating
Buy
Market Cap120.06M 
Earnings Date
10th Aug 2022
Alpha0.00 Standard Deviation0.34
Beta2.72 

Today's Price Range

0.89001.07

52W Range

0.32104.58

5 Year PE Ratio Range

-8.20-9.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
18.36%
1 Month
5.94%
3 Months
80.80%
6 Months
-10.08%
1 Year
-79.02%
3 Years
-
5 Years
-97.83%
10 Years
-95.60%

TickerPriceChg.Chg.%
AWH1.070.127913.58
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
47.40
-498.70
-494.80
-382.70
5.93
RevenueValueIndustryS&P 500US Markets
5.41M
0.05
23.85
18.89
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.08-0.080.00
Q04 2021-0.09-0.0811.11
Q03 2021-0.08-0.09-12.50
Q02 2021-0.06-0.060.00
Q01 2021-0.24-0.0579.17
Q04 2020-0.04-0.58-1 350.00
Q03 2020-0.04-0.040.00
Q02 2020--0.04-
Earnings Per EndEstimateRevision %Trend
3/2022 QR-0.0811.11Positive
6/2022 QR-0.0633.33Positive
12/2022 FY-0.30-400.00Negative
12/2023 FY-0.32-540.00Negative
Next Report Date10th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume368.67K
Shares Outstanding112.21K
Shares Float85.19M
Trades Count1.43K
Dollar Volume359.85K
Avg. Volume495.05K
Avg. Weekly Volume327.59K
Avg. Monthly Volume259.16K
Avg. Quarterly Volume898.40K

Aspira Women's Health Inc. (NYSE: AWH) stock closed at 1.07 per share at the end of the most recent trading day (a 13.58% change compared to the prior day closing price) with a volume of 368.67K shares and market capitalization of 120.06M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 53 people. Aspira Women's Health Inc. CEO is Valerie Palmieri.

The one-year performance of Aspira Women's Health Inc. stock is -79.02%, while year-to-date (YTD) performance is -39.55%. AWH stock has a five-year performance of -97.83%. Its 52-week range is between 0.321 and 4.575, which gives AWH stock a 52-week price range ratio of 17.61%

Aspira Women's Health Inc. currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 4.59, a price-to-sale (PS) ratio of 19.13, a price to cashflow ratio of 18.60, a PEG ratio of 2.32, a ROA of -78.07%, a ROC of -84.60% and a ROE of -98.41%. The company’s profit margin is 5.93%, its EBITDA margin is -494.80%, and its revenue ttm is $5.41 Million , which makes it $0.05 revenue per share.

Of the last four earnings reports from Aspira Women's Health Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Aspira Women's Health Inc.’s next earnings report date is 10th Aug 2022.

The consensus rating of Wall Street analysts for Aspira Women's Health Inc. is Strong Buy (1), with a target price of $3, which is +180.37% compared to the current price. The earnings rating for Aspira Women's Health Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aspira Women's Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of 36.00%.

Aspira Women's Health Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.58, ATR14 : 0.13, CCI20 : 100.32, Chaikin Money Flow : -0.02, MACD : 0.04, Money Flow Index : 70.72, ROC : -3.87, RSI : 52.87, STOCH (14,3) : 58.21, STOCH RSI : 0.80, UO : 38.89, Williams %R : -41.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aspira Women's Health Inc. in the last 12-months were: Nicole Sandford (Buy at a value of $74 892), Valerie B. Palmieri (Buy at a value of $24 918)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aspira Women's Health Inc.

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.

CEO: Valerie Palmieri

Telephone: +1 512 519-0400

Address: 12117 Bee Caves Road, Building Three, Austin 78738, TX, US

Number of employees: 53

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

59%41%

Bearish Bullish

54%46%


News

Stocktwits